Retraction of scientific publictions (June 2010)

Retraction. Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DC.

A series of papers were retracted from this project. One author, Suresh Radhakrishnan, was found to have misconduct in this case. The original paper was published in 2006 by Blocki FA, Radhakrishnan S, Van Keulen VP, Heckman KL, Ciric B, Howe CL, Rodriguez M, Kwon E, Pease LR.

Journal: FASEB J , June 2010.

Retraction: "Apparent role of traveling metabolic waves in oxidant release by living neutrophils" and "Dissipative metabolic patterns respond during neutrophil transmembrane signaling".

The above two papers were retracted due to unavailability of the original source data. The original articles were Petty HR, Kindzelskii AL. of 2001 and Kindzelskii AL, Petty HR. of 2002

Journal: Proc Natl Acad Sci U S A. , June 2010.

Retraction: cAbl tyrosine kinase mediates reactive oxygen species- and caveolin-dependent AT1 receptor signaling in vascular smooth muscle: role in vascular hypertrophy.

An institutional investigation found wrongdoing of one of the authors, Zuo L. The paper was retracted by the affiliated institution and the original article was published in 2005 by Ushio-Fukai M, Zuo L, Ikeda S, Tojo T, Patrushev NA, Alexander RW.

Journal: Circ Res , June 2010.

RETRACTION: Overexpression of caveolin-1 in adult T-cell leukemia.

The paper cited above was retracted by the last author who took full responsibility of duplicating some data. The original paper was published in 2010 by Sawada S, Ishikawa C, Tanji H, Nakachi S, Senba M, Okudaira T, Uchihara J-N,Taira N, Ohshiro K, Yamada Y, Tanaka Y, Uezato H, Ohshima K, Sasai K, Burgering B.M.T., Duc Dodon M, Fujii M, Sunakawa H, and Mori N.

Journal: Blood , June 2010.

RETRACTION: Aberrant expression of the transcription factor Twist in adult T-cell leukemia.

The paper cited above was retracted by the last author who took full responsibility of duplicating some data. The original paper was published in 2010 by Tanji H, Ishikawa C, Sawada S, Nakachi S, Takamatsu R, Matsuda T, Okudaira T, Uchihara J-N, Ohshiro K,Tanaka Y, Senba M, Uezato H, Ohshima K, Duc Dodon M, Wu K-J, and Mori N.

Journal: Blood , June 2010.

Retraction: Predicting the site of origin of tumors by a gene expression signature derived from normal tissues.

This article was retracted due to a processing error of microarray data. The original paper was published in 2009 by E Staub, H-J Buhr and J Gröne.

Journal: Oncogene , June 2010.

Retraction: Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells.

A series of papers have been retracted from this study. One author, Suresh Radhakrishnan, was found to have misconduct in this case. The original paper was published in 2003 by Suresh Radhakrishnan, Loc T. Nguyen, Bogoljub Ciric, Daren R. Ure, Bin Zhou, Koji Tamada, Haidong Dong, Su-Yi Tseng, Tahiro Shin, Drew M. Pardoll, Lieping Chen, Robert A. Kyle, Moses Rodriguez, and Larry R. Pease.

Journal: J Immunol , June 2010.

Retraction: Blockade of allergic airway inflammation following systemic treatment with a B7-dendritic cell (PD-L2) cross-linking human antibody.

A series of papers have been retracted from this study. One author, Suresh Radhakrishnan, was found to have misconduct in this case. The original paper was published in 2004 by Suresh Radhakrishnan, Koji Iijima, Takao Kobayashi, Moses Rodriguez, Hirohito Kita, and Larry R. Pease.

Journal: J Immunol , June 2010.

Retraction: B7-DC/PD-L2 cross-linking induces NF-kappaB-dependent protection of dendritic cells from cell death.

A series of papers have been retracted from this study. One author, Suresh Radhakrishnan, was found to have misconduct in this case. The original paper was published in 2007 by Suresh Radhakrishnan, Loc T. Nguyen, Bogoljub Ciric, Virginia P. Van Keulen, and Larry R. Pease.

Journal: J Immunol , June 2010.

Retraction: Induction of a Th1 Response from Th2-Polarized T Cells by Activated Dendritic Cells: Dependence on TCR:Peptide-MHC Interaction, ICAM-1, IL-12, and IFN-gamma.

A series of papers have been retracted from this study. One author, Suresh Radhakrishnan, was found to have misconduct in this case. The original paper was published in 2007 by Wiehagen KR, Pulko V, Van Keulen V, Faubion WA, Knutson KL, Pease LR.

Journal: J Immunol , June 2010.

Retraction: Reprogrammed FoxP3+ T Regulatory Cells Become IL-17+ Antigen-Specific Autoimmune Effectors In Vitro and In Vivo

A series of papers have been retracted from this study. One author, Suresh Radhakrishnan, was found to have misconduct in this case. The original paper was published in 2008 by Cabrera R, Schenk EL, Nava-Parada P, Bell MP, Van Keulen VP, Marler RJ, Felts SJ, Pease LR.

Journal: J Immunol , June 2010.

Retraction: TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells.

A series of papers have been retracted from this study. One author, Suresh Radhakrishnan, was found to have misconduct in this case. The original paper was published in 2008 by Arneson LN, Upshaw JL, Howe CL, Felts SJ, Rodriguez M, Pease LR, Colonna M.

Journal: J Immunol , June 2010.

January 2009    February 2009    March 2009    April 2009    May 2009    June 2009    July 2009    August 2009    September 2009    October 2009    November 2009    December 2009    January 2010    February 2010    March 2010    April 2010    May 2010    June 2010    July 2010   
Site News
New feature:
You can add comments on protocols now. Just go to any individual method page and click on the "Add a comment" link.

Highlight of the month
Metformin: New mechanism of old drug

Metformin, one of the most effective antidiabetic drugs, remains on market for a long time. Yet, the mechanisms of action are still elusive. Past studies point to LKB1/AMPK axis as the mediator of gluoneogenesis regulation. A recent report challenges this notion and provides evidence suggesting metformin can function in the absence of LKB1/AMPK.

Foretz and colleagues found metformin suppresses glucose production in wildtype primary hepatocytes dose-dependently. To their surprise, this suppression remains effective in AMPK deficient hepatocytes. They went further to show there is no difference between wildtype and AMPK liver specific knockout mice for glucose regulation by metformin. Similarly, LKB1, the upstream kinase of AMPK, is not required for glucose lowering effects of metformin in hepatocytes and in animals. More importantly, Foretz et al found metformin treatment reduces energy state of primary hepatocytes and in livers of mice, which is probably the primary reason of decreased glucose production.

The new mechanism proposed by Foretz et al raises number of interesting questions, such as the target of metformin, the mitochondria changes after treatment, beta oxidation, glycolysis. Answers for them will provide more insights about the action of metformin and clear understanding of type II diabetes. ... Read more highlights.